Related Experiment Video
Updated: Aug 20, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Apoptosis-stimulating protein of p53-2 (ASPP2/53BP2L) is an E2F target gene
1Department of Medicine, Division of Hematology and Medical Oncology, L586B, Oregon Health & Science University, Portland, OR 97239, USA.
Abstract:
The p53 pathway is a central apoptotic regulator. Deregulation of the Rb/E2F pathway occurs in a majority of tumors, resulting in both unrestrained proliferation and enhanced apoptosis sensitivity via p53-dependent and independent mechanisms. However, the mechanisms coupling the p53 and Rb/E2F pathways remain incompletely understood. We report that ASPP2/53BP2L, a p53/p73-binding protein that promotes p53/p73-dependent apoptosis, is an E2F target gene. The ASPP2/53BP2L promoter was identified and ectopic expression of transcription-competent E2F-1 (E2F-2 and E2F-3) stimulated an ASPP2/53BP2L promoter-luciferase reporter. Mutational analysis of the ASPP2/53BP2L promoter identified E2F-binding sites that cooperate for E2F-1 induction and basal repression of ASPP2/53BP2L. Moreover, endogenous ASPP2/53BP2L levels increased after E2F-1 expression, and E2F-1 bound the endogenous ASPP2/53BP2L promoter after chromatin immunoprecipitation. Typical for an E2F target, ASPP2/53BP2L expression was maximal in early S-phase. Thus, ASPP2/53BP2L is downstream of E2F, suggesting that it functions as a common link between the p53/p73 and Rb/E2F apoptotic pathways.
Insights
The ASPP2/53BP2L gene, a regulator of apoptosis, is controlled by the Rb/E2F pathway. This discovery reveals ASPP2/53BP2L as a crucial link connecting the p53 and Rb/E2F apoptotic signaling pathways in cancer.
Area of Science:
- Molecular Biology
- Cancer Biology
- Cellular Signaling
Background:
- The p53 pathway is a key regulator of apoptosis.
- The Rb/E2F pathway is frequently deregulated in cancer, impacting proliferation and apoptosis.
- The precise mechanisms linking p53 and Rb/E2F pathways are not fully understood.
Purpose of the Study:
- To investigate the relationship between the p53 and Rb/E2F apoptotic pathways.
- To identify novel targets of the Rb/E2F pathway involved in apoptosis regulation.
- To elucidate the role of ASPP2/53BP2L in the context of these signaling networks.
Main Methods:
- Promoter-luciferase reporter assays to identify E2F-responsive elements.
- Mutational analysis of the ASPP2/53BP2L promoter.
- Chromatin immunoprecipitation (ChIP) to assess E2F binding to the ASPP2/53BP2L promoter.
- Analysis of endogenous ASPP2/53BP2L expression in relation to E2F-1 levels and cell cycle phase.
Main Results:
- ASPP2/53BP2L was identified as a direct E2F target gene.
- Ectopic E2F-1, E2F-2, and E2F-3 expression upregulated the ASPP2/53BP2L promoter activity.
- Mutational analysis revealed functional E2F-binding sites in the ASPP2/53BP2L promoter.
- Endogenous ASPP2/53BP2L levels increased upon E2F-1 expression, with E2F-1 binding to the promoter.
- ASPP2/53BP2L expression peaked in early S-phase, characteristic of E2F targets.
Conclusions:
- ASPP2/53BP2L is a downstream target gene regulated by the Rb/E2F pathway.
- ASPP2/53BP2L acts as a molecular bridge connecting the p53/p73 and Rb/E2F apoptotic pathways.
- This finding provides new insights into the coordinated regulation of apoptosis in cancer.
Related Concept Videos
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Negative Regulator Molecules
Cell Specific Gene Expression
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle

